Our data indicate that immune markers such as chromium-specific T cell proliferation, IL-10 deficiency, and Treg metabolic dysfunction (reduced ECAR) could serve as complementary diagnostic indicators to better classify hypersensitivity phenotypes. The gene discussed is IL10; the disease is hyperinsulinemic hypoglycemia, familial, 4.